HHS announces major downsizing, cutting 20,000 jobs total across FDA, CDC, and NIH. New Administration for Healthy America to ...

After an IPO this year, Metsera is making its best effort to catch up to obesity drug giants Eli Lilly and Novo Nordisk.

HHS’ plans to eliminate almost 20% of the FDA’s staff will likely take a major toll on policy, communications and other ...

President Donald Trump’s threatened tariffs on pharmaceuticals are incentivizing drugmakers to build more manufacturing ...

AI scribes reduce burnout but show mixed results on time savings and financial returns. Study included Abridge, Nabla, ...

Miami startup Galatea Bio raises $25M to sequence genetic diversity of 10M people globally, focusing on underrepresented ...

Nkarta cuts 53 jobs, Felix Baker joins Bicycle board, Kelso gets £140M, Arbutus cuts 19 jobs, Ascletis shifts to obesity, ...

Chiesi plans Milan factory, Bharat Biotech builds CGT site, Aspen faces FDA warning, Currax adds Contrave site, Redwire aids ...

Miga Health found itself in a set of circumstances that other health tech startups that provide patient services are likely ...

Equillium's itolizumab fails Phase 3 trial for acute graft-versus-host disease, but company plans FDA accelerated approval ...

Candel Therapeutics' CAN-2409 showed marginal survival benefit in lung cancer trial, with better results in non-squamous ...

The FDA has approved Exelixis' cancer drug Cabometyx to treat advanced neuroendocrine tumors inside and outside of the ...